DHRDanaher Corp

$135.77
$1.25 (1%)

Create a FREE Account to View Full Report

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.
Analyst ForecastNext 12 months ➝Current Price$135.7752-week High$147.3352-week Low$94.59MEAN$154.88+14.07%HIGH$174.00+28.16%LOW$142.00+4.59%
  • Last Price$135.77
  • Previous Close$134.52
  • Change $1.25
  • Open$134.67
  • Volume758,005
  • Avg. Volume (100-day)2,216,202
  • Market Capitalization$97.52B
  • Days Range $134.53 - $136.29
  • 52-week Range $94.59 - $147.33
  • Dividend Yield0.51%
  • Ex. Dividend Date09/26/2019
  • P-E40
  • EPS3.38
  • Earnings Date02/04/2020
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Avg. Analyst Rec.
  • Beta-0.134
  • PEG Ratio2.26
  • Volatility0.41
  • Average True Range0.03